X0306 4 2013-04-29 0000890465 NPS PHARMACEUTICALS INC NPSP 0001192128 BESHAR LUKE M 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 EVP & CFO Common Stock 2013-04-29 4 M 0 4850 4.05 A 64030 D Common Stock 2013-04-29 4 S 0 4850 14.00 D 59180 D Stock Options 4.05 2013-04-29 4 M 0 4850 0 D 2017-11-20 Common Stock 4850 95150 D The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective December 14, 2012. On November 20, 2007, the Reporting Person received a grant of 200,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 28% on the first anniversary of the date of grant and 2% each month thereafter. /s/ Luke Beshar, by Edward Stratemeier as attorney-in-fact 2013-04-30